India's once-thriving public vaccine manufacturers were absent during the pandemic. This was not due to a lack of capability. The problem has been active neglect by the government .
Bangladesh could do for Covid-19 and other diseases what India did for HIV/AIDS: provide expensive therapeutic drugs globally at low prices. But its potential is constrained by a lack of indigenous…
